Loomis, Sayles & Company
GILD icon

Loomis, Sayles & Company’s Gilead Sciences GILD Stock Holding History

Loomis, Sayles & Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.87M Buy
46,442
+377
+0.8% +$49.7K 0.01% 426
2026
Q1 		$6.42M Sell
46,065
-15,424
-25% -$2.16M 0.01% 399
2025
Q4 		$7.55M Sell
61,489
-30,656
-33% -$3.73M 0.01% 390
2025
Q3 		$10.2M Buy
92,145
+36,524
+66% +$4.15M 0.01% 354
2025
Q2 		$6.17M Buy
55,621
+55,197
+13,018% +$5.87M 0.01% 415
2025
Q1 		$48K Sell
424
-228
-35% -$23.5K ﹤0.01% 625
2024
Q4 		$60K Sell
652
-22
-3% -$1.98K ﹤0.01% 631
2024
Q3 		$57K Sell
674
-163
-19% -$12.4K ﹤0.01% 617
2024
Q2 		$57K Sell
837
-2,731
-77% -$182K ﹤0.01% 619
2024
Q1 		$261K Sell
3,568
-78
-2% -$6K ﹤0.01% 501
2023
Q4 		$295K Sell
3,646
-195
-5% -$15.2K ﹤0.01% 482
2023
Q3 		$288K Buy
3,841
+2,988
+350% +$230K ﹤0.01% 489
2023
Q2 		$66K Buy
853
+52
+6% +$4.15K ﹤0.01% 578
2023
Q1 		$66K Sell
801
-525
-40% -$43.5K ﹤0.01% 580
2022
Q4 		$114K Buy
1,326
+813
+158% +$64.4K ﹤0.01% 535
2022
Q3 		$32K Sell
513
-3,716
-88% -$234K ﹤0.01% 591
2022
Q2 		$261K Sell
4,229
-80
-2% -$4.95K ﹤0.01% 481
2022
Q1 		$256K Sell
4,309
-510
-11% -$32.6K ﹤0.01% 529
2021
Q4 		$350K Sell
4,819
-315
-6% -$21.7K ﹤0.01% 529
2021
Q3 		$359K Sell
5,134
-728
-12% -$51.1K ﹤0.01% 512
2021
Q2 		$404K Sell
5,862
-24,762
-81% -$1.65M ﹤0.01% 511
2021
Q1 		$1.98M Buy
30,624
+30,230
+7,673% +$1.95M ﹤0.01% 445
2020
Q4 		$23K Sell
394
-15,607
-98% -$942K ﹤0.01% 616
2020
Q3 		$1.01M Buy
16,001
+13,352
+504% +$926K ﹤0.01% 452
2020
Q2 		$204K Buy
2,649
+1,908
+257% +$146K ﹤0.01% 500
2020
Q1 		$55K Sell
741
-29,525
-98% -$2.04M ﹤0.01% 555
2019
Q4 		$1.97M Sell
30,266
-28,868
-49% -$1.88M ﹤0.01% 453
2019
Q3 		$3.75M Sell
59,134
-9,407
-14% -$615K 0.01% 433
2019
Q2 		$4.63M Buy
68,541
+22,721
+50% +$1.49M 0.01% 416
2019
Q1 		$2.98M Buy
45,820
+9,512
+26% +$632K 0.01% 475
2018
Q4 		$2.27M Buy
36,308
+35,623
+5,200% +$2.49M 0.01% 488
2018
Q3 		$53K Sell
685
-4,676
-87% -$353K ﹤0.01% 612
2018
Q2 		$380K Buy
+5,361
New +$379K ﹤0.01% 587
2018
Q1 		– Sell
-161
Closed -$12K – 895
2017
Q4 		$12K Sell
161
-3,613
-96% -$274K ﹤0.01% 775
2017
Q3 		$306K Buy
+3,774
New +$289K ﹤0.01% 601
2017
Q1 		– Sell
-1,290
Closed -$92K – 984
2016
Q4 		$92K Sell
1,290
-77
-6% -$5.72K ﹤0.01% 677
2016
Q3 		$108K Buy
1,367
+77
+6% +$6.25K ﹤0.01% 662
2016
Q2 		$108K Sell
1,290
-301
-19% -$26.7K ﹤0.01% 653
2016
Q1 		$146K Buy
1,591
+301
+23% +$27.1K ﹤0.01% 660
2015
Q4 		$131K Sell
1,290
-256
-17% -$26.6K ﹤0.01% 692
2015
Q3 		$152K Sell
1,546
-3,671
-70% -$408K ﹤0.01% 719
2015
Q2 		$611K Sell
5,217
-870,883
-99% -$95.2M ﹤0.01% 600
2015
Q1 		$86M Sell
876,100
-53,510
-6% -$5.43M 0.24% 76
2014
Q4 		$87.6M Buy
929,610
+16,729
+2% +$1.73M 0.24% 77
2014
Q3 		$97.2M Sell
912,881
-72,403
-7% -$7.09M 0.28% 71
2014
Q2 		$81.7M Buy
985,284
+21,975
+2% +$1.71M 0.23% 100
2014
Q1 		$68.3M Buy
963,309
+136,158
+16% +$10.7M 0.19% 120
2013
Q4 		$62.2M Sell
827,151
-61,711
-7% -$4.3M 0.19% 121
2013
Q3 		$55.9M Sell
888,862
-28,453
-3% -$1.7M 0.18% 130
2013
Q2 		$47K Buy
+917,315
New +$47.8M 0.17% 144

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Loomis, Sayles & Company's GILD Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Gilead Sciences (GILD) stake by 0.82% in Q2 2026, buying an estimated $49.7K and bringing the position to 46,442 shares worth $5.87M. The position accounts for 0.01% of the portfolio, ranked #426.

Loomis, Sayles & Company first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $97.2M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Loomis, Sayles & Company held 46,442 shares of Gilead Sciences worth $5.87M as of Q2 2026.
  • Loomis, Sayles & Company bought 377 Gilead Sciences shares in Q2 2026, an estimated $49.7K.
  • Gilead Sciences made up 0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #426 holding.
  • Loomis, Sayles & Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
  • Loomis, Sayles & Company's Gilead Sciences position peaked at $97.2M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.